2022 Wellcare By Allwell Pharmacy Benefit Drug List Changes
Date: 12/03/21
Each year Wellcare By Allwell reviews the list of drugs covered by our plan as part of our annual drug list review process. This review may result in some medications having changes such as:
- Moving to a higher or lower tier.
- Being added or removed from the drug list.
- Having a new special requirement.
To assist providers, below is a list of drugs that will removed from the Wellcare By Allwell drug list, effective January 1, 2022. Formulary alternative(s) for these drugs are also included. Please note:
- This list is non-comprehensive but highlights the most commonly prescribed drugs impacted by this annual review.
- We may cover a temporary supply of up to 30 days if filled at a retail pharmacy, or 31 days if filled at a long-term care pharmacy during the first 90 days of the calendar year.
- For more details, please reference Wellcare By Allwell’s Evidence of Coverage.
What you need to do:
- Work with your patients currently taking any of the medications listed below to find other options. Often, a covered generic or alternative may be available.
- You should have received a fax with impacted Wellcare By Allwell members that lists alternatives. Please use this to guide your members’ transition.
Removed Drug List | Formulary Alternative |
|---|---|
AURYXIA | CALCIUM ACETATE (PHOS BINDER) CAP/TAB, SEVELAMER CARBONATE |
BRINZOLAMIDE OPHTH SUSP 1% | AZOPT, DORZOLAMIDE |
BYDUREON PEN (product discontinued) | BYDUREON BCISE AUTO INJ |
TRULANCE | LINZESS CAP, LUBIPROSTONE CAP |
If you determine that it is necessary for your patient to continue to receive the non-formulary drug in 2022, you will need to submit a Drug Coverage Determination Form as soon as possible. These forms are located on our website by visiting the Coverage Determinations and Redeterminations for Drugs webpage.
If you have any questions, please contact Wellcare By Allwell’s Pharmacy Department at 1-800-867-6564.